CD8A and neoplasm: The anti-tumor effectiveness of CD8+T cells has been demonstrated to be improved and the survival duration of mice with colon cancer lengthened in other studies using a combination of PLX3397(CSF-1R inhibitor), oncogenic virus, and anti-PD-1 antibody (110).